Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05933577 |
|---|---|
| Brief Title: | A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) |
| First Submitted : | June 27, 2023 |
| First Submitted that Met QC Criteria : | June 27, 2023 |
| First Posted : | July 6, 2023 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |